Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	20.37	75.85	63.01
Graham Fair Price	26.97	21.51	16.94
PEG	-34.31	0.51	-0.78
Price/Book	-1.54	12.42	12.61
Price/Cash Flow	73.38	-142.92	82.43
Prices/Earnings	-35.37	28.96	44.81
Price/Sales	54.67	12.96	8.38
Price/FCF	73.38	-142.92	82.43
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.12	0.55	0.53
Operating Margin	40.38	0.16	0.11
ROA	57.55	0.02	0.01
ROE	0.07	0.11	52.36
ROIC	0.04	0.04	-17.31
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	< 0.005	970.84
Dividends QOQ	< 0.005	0.01	1511.85
EBIT QOQ	-0.25	-0.08	67.63
EPS QOQ	-0.58	0.57	-1.62
FCF QOQ	-0.38	-1.58	-313.93
Revenue QOQ	0.19	-0.34	83.86
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	36.94	61.03	65.22
Days Sales Outstanding (DSO)	34.95	53.94	54.34
Inventory Turnover	2.44	1.47	-39.48
Debt/Capitalization	0.71	0.71	-0.07
Quick Ratio	0.66	0.64	-3.02
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.47	13.85	2.87
Cash	7.28	6.07	-16.59
Capex	-2.17	-0.45	79.42
Free Cash Flow	2.06	-1.20	-41.58
Revenue	20.27	13.27	-34.52
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.85	0.86	1.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.21	10.46	27.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating